Simon Wang
University College Hospital
3 Papers
Simon Wang is an academic researcher from University College Hospital. The author has contributed to research in topics: Internal medicine & Melanoma. The author has co-authored 1 publications.
Chat about Author
Papers
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System
Matthias Lechner,Yoko Takahashi,Mario Turri-Zanoni,Marco Ferrari,Jacklyn Liu,Nicholas Counsell,Davide Mattavelli,Vittorio Rampinelli,William Vermi,David A. Lombardi,Rami E. Saade,Ki Wan Park,Volker Hans Schartinger,Alessandro Franchi,Carla Facco,Fausto Sessa,Simonetta Battocchio,Tim R. Fenton,Francis Vaz,Paul O'Flynn,David Howard,Paul Stimpson,Simon Wang,Saiful Alam Hannan,Samit Unadkat,Jonathan Hughes,Raghav C. Dwivedi,Cillian T Forde,Premjit S Randhawa,Simon Gane,Jonathan Joseph,Peter J. Andrews,Manas Dave,Jason C. Fleming,David J Thomson,Tianyu Zhu,Andrew E. Teschendorff,G.T. Royle,C Steele,Joaquin E. Jimenez,Jan Laco,Eric W. Wang,Carl H. Snyderman,Peter D. Lacy,Robbie S. R. Woods,James P. O'Neill,Anirudh Saraswathula,Raman Preet Kaur,Tianna Zhao,Murugappan Ramanathan,Gary L. Gallia,Nyall London,Quynh-Thu Le,Robert B. West,Zara M. Patel,Jayakar V. Nayak,Peter H. Hwang,Mario Hermsen,José Luis Llorente,Fabio Facchetti,Piero Nicolai,Paolo Bossi,Paolo Castelnuovo,Amrita Jay,Dawn Carnell,Martin Forster,Diana Bell,Valerie J. Lund,Ehab Y. Hanna +68 more
TL;DR: The potential utility of further stratifying the T3 stage by sinus involvement is demonstrated and promising data on the benefit of immune checkpoint inhibitors for recurrent, persistent, or metastatic disease is presented, with implications for future clinical trials in this field.
Multicenter Analysis of Clinical Outcomes and Biomarkers of Esthesioneuroblastoma
Matt Lechner,Mario Hermsen,Mario Turri-Zanoni,Volker Hans Schartinger,Sam Helman,Jordan Varghese,C. Arturo Solares,Kelly R. Magliocca,Simon Wang,Susanne Sprung,David Howard,Nils W. Engel,David Capper,Ulrich Schueller,Martin Forster,Amrita Jay,Cillian T. Forde,Jozsef Dudas,Herbert Riechelmann,R. Peter Manes,Wendell G. Yarbrough,Jose L. Llorente,Sarah K. Wise,Paolo Castelnuovo,Valerie J. Lund +24 more
Multicenter Analysis of Clinical Outcomes of Sinonasal Mucosal Melanoma
Matthias Lechner,Yoko Takahashi,Mario Turri-Zanoni,Marco Ferrari,Jacklyn Liu,Nicholas Counsell,Davide Mattavelli,Vittorio Rampinelli,Davide Lombardi,Rami E. Saade,Ki Wan Park,Volker Hans Schartinger,Alessandro Franchi,Roberta Maragliano,Simonetta Battocchio,Oscar Emanuel,Tim R. Fenton,Francis Vaz,Paul O'Flynn,David Howard,Paul Stimpson,Simon Wang,Saiful Alam Hannan,Samit Unadkat,Jonathan Hughes,Raghav C. Dwivedi,Cillian T Forde,Premjit S Randhawa,Simon Gane,Jonathan Joseph,Peter J. Andrews,Tianyu Zhu,Andrew E. Teschendorff,G.T. Royle,H. Bewicke-Copley,C Steele,Luke Williams,Joaquin E. Jimenez-Garcia,Eric W. Wang,Carl H. Snyderman,Peter D. Lacy,Robbie S. R. Woods,James P. O'Neill,Quynh-Thu Le,Robert B. West,Zara M. Patel,Jayakar V. Nayak,Peter H. Hwang,Mario Hermsen,José A. García Llorente,Fabio Facchetti,Piero Nicolai,Paolo Bossi,Paolo Castelnuovo,Amrita Jay,Dawn Carnell,Martin Forster,Diana Bell,Valerie J. Lund,Ehab Y. Hanna +59 more
TL;DR: In this paper , the role of adjuvant therapy in the treatment of sinonasal mucosal melanoma (SNMM) remains controversial, and the authors propose a novel adjuant therapy for this rare malignancy.